The ROE as of November 2024 (TTM) for First Wave BioPharma, Inc. (FWBI) is -28.76%

According to First Wave BioPharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -28.76%. This represents a change of -83.24% compared to the average of -171.60% of the last 4 quarters.

First Wave BioPharma, Inc. (FWBI) Historical ROE (quarterly & annually)

How has FWBI ROE performed in the past?

The mean historical ROE of First Wave BioPharma, Inc. over the last ten years is -42.09%. The current -28.76% ROE has changed -31.68% with respect to the historical average. Over the past ten years (40 quarters), FWBI's ROE was at its highest in in the December 2020 quarter at 658.93%. The ROE was at its lowest in in the June 2023 quarter at -474.99%.

First Wave BioPharma, Inc. (FWBI) ROE by Quarter and Year

Discovering the peaks and valleys of First Wave BioPharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

First Wave BioPharma, Inc. (FWBI) Average ROE

How has FWBI ROE performed in the past?

The current ROE of First Wave BioPharma, Inc. (FWBI) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

First Wave BioPharma, Inc. (FWBI) ROE vs. Peers

How is FWBI’s ROE compared to its peers?

First Wave BioPharma, Inc.’s ROE is greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Blue Water Vaccines, Inc. (-104.77%), greater than PaxMedica, Inc. Common Stock (-3167.06%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Hillstream BioPharma, Inc. (-172.28%), greater than Dermata Therapeutics, Inc. (-247.40%), less than Panbela Therapeutics, Inc. (304.71%), less than ContraFect Corporation (376.50%), less than SeaStar Medical Holding Corporation (443.82%), greater than Virios Therapeutics, Inc. (-130.35%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than Sigilon Therapeutics, Inc. (-74.73%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Zura Bio Limited (-39.61%), less than Apexigen, Inc. (48.27%), greater than Phio Pharmaceuticals Corp. (-134.57%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Immix Biopharma, Inc. (-102.10%),

Build a custom stock screener for First Wave BioPharma, Inc. (FWBI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like First Wave BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

First Wave BioPharma, Inc. (FWBI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like First Wave BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.